Back to Search Start Over

Long-term remission of tumefactive relapsing multiple sclerosis after alemtuzumab rescue treatment in an adolescent patient.

Authors :
Baroncini, Damiano
Annovazzi, P.
Guaschino, C.
Minonzio, G.
Hametner, S.
Stadelmann, C.
Comi, G.
Ghezzi, A.
Zaffaroni, M.
Source :
Multiple Sclerosis & Related Disorders; Jun2020, Vol. 41, pN.PAG-N.PAG, 1p
Publication Year :
2020

Abstract

• Multiple sclerosis can present with tumefactive relapsing lesions. • Brain biopsy could help in differential diagnosis. • Alemtuzumab led to a sustained remission after 4 years of follow-up. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
22110348
Volume :
41
Database :
Supplemental Index
Journal :
Multiple Sclerosis & Related Disorders
Publication Type :
Academic Journal
Accession number :
143858803
Full Text :
https://doi.org/10.1016/j.msard.2020.102061